Form4insider filings, from the source

Insider holders · CIK 0001576885

Acumen Pharmaceuticals, Inc. · ABOS

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
RA Capital Nexus Fund II, L.P.Director—588,850588,850Jun 5, 2026 · 5:12 pm EDTForm 4
Rajeev M. ShahDirector—588,850588,850Jun 5, 2026 · 5:12 pm EDTForm 4
Peter KolchinskyDirector—588,850588,850Jun 5, 2026 · 5:12 pm EDTForm 4
RA CAPITAL MANAGEMENT, L.P.Director—588,850588,850Jun 5, 2026 · 5:12 pm EDTForm 4
RA Capital Healthcare Fund LPDirector—588,850588,850Jun 5, 2026 · 5:12 pm EDTForm 4
John A Stalfort IIIDirector220,624—220,624Jun 5, 2026 · 4:30 pm EDTForm 4
Laura StoppelDirector48,300—48,300Jun 5, 2026 · 4:27 pm EDTForm 4
Jeffrey L. IvesDirector48,300—48,300Jun 5, 2026 · 4:29 pm EDTForm 4
Kimberlee C DrapkinDirector48,300—48,300Jun 5, 2026 · 4:31 pm EDTForm 4
Nathan B FountainDirector48,150—48,150Jun 10, 2026 · 4:51 pm EDTForm 4
Derrell PorterDirector35,500—35,500Jun 17, 2026 · 5:10 pm EDTForm 4
George GolumbeskiDirector35,500—35,500Jun 5, 2026 · 4:28 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.